Furthermore, treating the patient-derived glioblastoma tumor spheres with an ABCG2 inhibitor reduced self-renewal of these cells suggesting that ABCG2 is important for maintaining their stemness [97]. This evidence concerns the gene ABCG2 and glioblastoma.